# Prostatic Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)

> **NCT04563221** · NA · WITHDRAWN · sponsor: **Andrew Picel**

## Conditions studied

- Benign Prostatic Hyperplasia
- Lower Urinary Tract Symptoms

## Interventions

- **DEVICE:** Prostatic artery embolization

## Key facts

- **NCT ID:** NCT04563221
- **Lead sponsor:** Andrew Picel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-05-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding not approved
- **Last updated:** 2021-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04563221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04563221, "Prostatic Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04563221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*